Explore 3 Stock Ideas & Industry Insights Download Free Report

Captiva Verde Land Corp

Healthcare US CPIVF

0.0285USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.00450.05
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap4.66M
  • Volume25000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.20276M
  • Revenue TTM0.17M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.10M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Income before tax -0.93195M -0.58700M -6.08500M -3.62523M -3.76885M
Minority interest - - - - -
Net income -1.03732M -3.37400M -6.08500M -3.62523M -3.76885M
Selling general administrative 1.60M 1.07M 1.22M 1.27M 0.94M
Selling and marketing expenses - - 0.08M - -
Gross profit - - 0.16M - -
Reconciled depreciation - - - 0.00000M 0.04M
Ebit - - -5.95500M -1.27861M -3.78245M
Ebitda -1.67550M - -6.05600M -1.26385M -3.74629M
Depreciation and amortization - 1.07M -0.10100M - 0.04M
Non operating income net other - - - - -
Operating income -1.67550M -1.07400M -1.07900M -1.26385M -3.78245M
Other operating expenses 1.68M 1.07M 1.20M 1.33M 3.90M
Interest expense - 0.00000M 0.03M 0.04M 0.01M
Tax provision - - - - -
Interest income - - - - -
Net interest income - 0.00000M -0.02903M -0.03843M -0.01252M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -1.14197M - 0.13M
Total revenue 0.00000M 0.00000M 0.17M 0.00000M 0.00000M
Total operating expenses 1.68M 1.07M 0.17M 1.33M 3.90M
Cost of revenue - - 0.01M - -
Total other income expense net 0.74M 0.49M -5.00600M -2.25599M 0.15M
Discontinued operations - - - - -
Net income from continuing ops -0.93207M -0.58660M -6.08511M -3.62523M -3.76885M
Net income applicable to common shares - - - -3.62523M -3.76885M
Preferred stock and other adjustments - - - - -
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Total assets 4.46M 7.76M 9.10M 9.76M 11.30M
Intangible assets - - 3.97M - -
Earning assets - - - - -
Other current assets 0.00492M 2.68M 0.26M - -
Total liab 2.54M 3.81M 2.09M 1.83M 2.54M
Total stockholder equity 1.92M 3.96M 7.01M 7.93M 8.76M
Deferred long term liab - - - - -
Other current liab 2.54M 0.46M 0.19M 0.99M 0.60M
Common stock 16.34M 17.81M 17.68M 14.00M 11.31M
Capital stock 16.35M 17.81M 17.68M 14.00M 11.31M
Retained earnings -21.71570M -20.68115M -17.30682M -11.22171M -7.59648M
Other liab - - - - -
Good will - - - - -
Other assets - - 0.00000M 5.59M 5.95M
Cash 0.00225M 0.01M 0.00544M 0.02M 0.09M
Cash and equivalents - - - - -
Total current liabilities 2.54M 3.81M 2.09M 1.83M 2.50M
Current deferred revenue - - -0.19170M - -
Net debt -0.00225M -0.01033M 0.19M 0.82M 1.85M
Short term debt - - 0.19M 0.83M 1.90M
Short long term debt - - 0.19M 0.83M 1.87M
Short long term debt total - - 0.19M 0.83M 1.94M
Other stockholder equity - 6.86M 6.63M 5.15M 5.05M
Property plant equipment - - - 4.15M 5.19M
Total current assets 1.76M 4.16M 0.27M 0.02M 0.16M
Long term investments - - - - -
Net tangible assets - - - 7.93M 8.76M
Short term investments 0.11M 0.00000M - - -
Net receivables 1.64M 1.47M - - 0.00507M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - 3.35M 1.90M 0.99M 0.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.29M -0.02856M 0.00132M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 2.61M 3.91M 5.59M 5.95M
Deferred long term asset charges - - - - -
Non current assets total 2.70M 3.60M 8.83M 9.74M 11.14M
Capital lease obligations - - - 0.00000M 0.07M
Long term debt total - - - - -
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Investments 0.16M -0.03920M -2.03025M -0.18048M -1.40991M
Change to liabilities - - - 0.65M 0.28M
Total cashflows from investing activities 0.08M -0.03920M -2.03025M -0.18048M -1.40491M
Net borrowings - 0.00000M -0.67105M 0.20M 0.63M
Total cash from financing activities 0.89M 0.46M 2.66M 0.58M 1.78M
Change to operating activities - - - 0.07M 0.41M
Net income -0.93195M -3.37433M -6.08511M -3.62523M -3.76885M
Change in cash -0.00814M 0.00489M -0.01014M -0.07163M 0.07M
Begin period cash flow 0.01M 0.00544M 0.02M 0.09M 0.02M
End period cash flow 0.00225M 0.01M 0.00544M 0.02M 0.09M
Total cash from operating activities -0.98293M -0.38210M -0.63818M -0.46885M -0.30500M
Issuance of capital stock 0.20M 0.00000M 3.28M 0.38M 0.83M
Depreciation - - - 0.00000M 0.04M
Other cashflows from investing activities -0.04999M - - -0.02078M -0.47228M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.22M 0.46M 0.05M 0.20M 0.98M
Change to netincome - - - 2.43M 2.74M
Capital expenditures 0.03M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.34M 2.26M 0.56M 0.72M 0.69M
Stock based compensation 0.53M 0.00000M 0.00000M 0.18M 0.00000M
Other non cash items -0.39029M 0.73M 4.88M 2.25M 2.74M
Free cash flow -1.01292M -0.38210M -0.63818M -0.46885M -0.30500M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CPIVF
Captiva Verde Land Corp
- -% 0.03 - - 49.98 11.60 62.19 -2.0273
ZTS
Zoetis Inc
0.95 1.25% 76.84 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
0.42 1.37% 30.98 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
6.43 4.31% 155.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
0.48 1.12% 43.42 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

Captiva Verde Wellness Corp. operates as a real estate company. It also invests in sports. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Captiva Verde Wellness Corp. was incorporated in 2015 and is based in Vancouver, Canada.

Captiva Verde Land Corp

1500 Royal Centre, Vancouver, BC, Canada, V6E 4N7

Key Executives

Name Title Year Born
Mr. Jeffrey J. Ciachurski CEO & Non-Independent Director 1960
Mr. Anthony Bob Balic Chief Financial Officer 1982
Mr. Santiago Garin Pres of Esmeralda Health of Mexico NA
Mr. Len Wood Exec. VP NA
Mr. Jeffrey J. Ciachurski Executive Chairman 1960
Mr. Anthony Bob Balic CPA CFO & Corporate Secretary 1982
Mr. Brian Conlan Chief Executive Officer NA
Mr. Santiago Garin President of Esmeralda Health of Mexico NA
Mr. Len Wood Executive Vice President NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.